Vital Prospects Clinical Research Institute PC — Tulsa, Oklahoma

Vital Prospects Clinical Research Institute PC is a clinical research site located in Tulsa, Oklahoma, United States 74136.

Crixeo Clinical Trials Trust Score: 24/100 (FAILING). This profile has not yet been claimed by the site owner.

Vital Prospects Clinical Research Institute PC has participated in 29 clinical trials with 4 currently active.

Therapeutic areas: Eosinophilic Esophagitis, Alopecia Areata, Active Non-segmental Vitiligo.

Sponsors: Ellodi Pharmaceuticals, LP, Concert Pharmaceuticals, Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Tulsa

Browse all research sites in Oklahoma · View every site in Tulsa

Sponsor Feasibility Report

Trust Score: 24/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Vital Prospects Clinical Research Institute PC?

Vital Prospects Clinical Research Institute PC has a Crixeo Trust Score of 24/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Vital Prospects Clinical Research Institute PC conducted?

Vital Prospects Clinical Research Institute PC has 29 clinical trials on record, with 4 currently active. Their work covers Eosinophilic Esophagitis, Alopecia Areata, Active Non-segmental Vitiligo.

Is Vital Prospects Clinical Research Institute PC accredited by Crixeo Clinical Trials?

Vital Prospects Clinical Research Institute PC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Vital Prospects Clinical Research Institute PC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.